Onco-hematology Molecular Testing Market, By Product Type (Services and Assay Kits & Reagents), By Cancer Type (Lung Cancer, Hematological Cancer, Breast Cancer and Colorectal Cancer), By Technology (qPCR, dPCR and Next-Generation Sequencing), By End-use (Reference Laboratories and Hospitals), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Onco-hematology molecular testing market size was valued at USD 530.8 Million in 2022, expanding at a CAGR of 13.3% from 2023 to 2030.
Hematology molecular testing is the diagnostic procedure utilized in the field of hematological oncology to monitor and detect blood cancer and related disease. These tests play an essential role in the early diagnosis, treatment, and detection of hematological malignancies including myeloma, leukemia, and lymphoma. Moreover, it also involves numerous technologies such as flow cytometry, molecular testing, next-generation sequencing, and cytogenetics. In addition, these tests assist identify chromosomal abnormalities, genetic mutations, and other molecular markers associated with other types of blood cancers. By examining these makers healthcare professionals can make actual diagnoses, tailor treatment plans, and determine disease progression to individual patients.
Onco-hematology Molecular Testing Market- Market Dynamics
- The rising prevalence of cancer cases and new advancements in molecular diagnostics tests may propel the market demand
The demand for diagnosis is driven by the increasing prevalence of cancer cases across the globe, which is fueling up the onco-hematology molecular testing market. Additionally, cancer cases are contributing to the growing requirement for early detection and preventive medicine. As a result, such factors increase the demand steadily for the onco-hematology molecular testing market. Moreover, molecular diagnostics tests for oncology are becoming more popular as diagnostic testing End-use advances. In cancer genome sequencing, tumor models, computational analysis, and innovative cancer research methods, numerous passages are being made. However, in cancer care, the cost of molecular diagnostic testing is comparably higher and it varies depending on the type of therapy which is expected to restrain the market growth over the forecast period.
Onco-hematology Molecular Testing Market- Key Insights
- As per the analysis shared by our research analyst, the global onco-hematology molecular testing market is estimated to grow annually at a CAGR of around 13.3% over the forecast period (2023-2030)
- The onco-hematology molecular testing industry is projected to grow at a significant rate due to the growing number of healthcare infrastructure and well-established healthcare infrastructure
- Based on technology segmentation, next-generation sequencing was predicted to show maximum market share in the year 2022
- Based on product type segmentation, services was the leading type in 2022
- On the basis of region, Asia-Pacific was the leading revenue generator in 2022
Onco-hematology Molecular Testing Market- Segmentation Analysis:
The global onco-hematology molecular testing market is segmented on the basis of product type, cancer type, technology, end-use, and region.
The market is divided into two categories based on product type: services and assay kits & reagents. The services segment is likely to maintain its dominance over the forecast period owing to its increasing incidence of non-Hodgkin lymphoma, leukemia, and myeloma. Additionally, the segment growth is driven by the increasing awareness regarding several treatment therapies including personalized medicines. The rising availability of services provided for the diagnosis of myeloma is attributed to boosting the growth of the market.
The market is divided into four categories based on cancer type: lung cancer, hematological cancer, breast cancer, colorectal cancer, and others. The other cancer segment is accounted to witness the highest growth rate in the market. The rise in the prevalence of various types of cancer such as gastric cancer, prostate cancer, and pancreas cancer globally propel the segment growth.
The market is divided into three categories based on technology: qPCR, dPCR, next-generation sequencing, and Others. The next-generation sequencing segment is likely to possess the largest revenue share. The numerous advantages provided by this technology including specificity and more sensitivity are expected to fuel the segment growth. Moreover, next-generation sequencing tests are utilized to examine low levels of cancer cells remaining in patients diagnosed with lymphoblastic leukemia. The FDA approvals for NGS-based tests are attributed to driving the market growth.
The market is divided into two categories based on end-use: reference laboratories, hospitals, and others. The hospital segment is expected to dominate the largest revenue share. The rising number of cancer patients\' visits for treatment and diagnosis is likely to drive the growth. Moreover, the rise in the incidence rate of blood cancers, the presence of healthcare professionals to conduct diagnostic tests, & monitor the disease, and the availability of specialized laboratory settings is witnessing growth owing to above mention factors.
Onco-hematology Molecular Testing Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Onco-hematology Molecular Testing Market- Competitive Landscape:
Rising healthcare costs and government initiatives aimed at improving cancer treatment and diagnosis are driving market revenue growth. Governments across the world are funding the development of new cancer diagnostic equipment and treatment regimens. Moreover, increasing cancer occurrence, increased need for customized medication, and technical developments in testing methodologies are some of the primary drivers driving market revenue growth. Market players are focusing to strengthen their business by adopting several strategies such as technology network development, mergers, R&D activities, and collaboration. For instance, in June 2022, Burning Rock Biotech Limited introduced that it has received a CE marking for its OverC™ Multi-Cancer Detection Blood Test manufactured in both the US and China facilities
Recent Developments:
- For instance, in May 2021, Roche and GenMark Diagnostics entered into a merger agreement in which Roche will fully acquire GenMark. Additionally, Roche aims to expand its portfolio of molecular diagnostics with GenMark’s expertise in syndromic testing through the acquisition.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET KEY PLAYERS
- Hoffmann-La Roche Ltd
- DiaSorin Molecular LLC
- Abbott
- Thermo Fisher Scientific Inc.
- Bayer AG
- GenMark Diagnostics, Inc
- Biocartis
- BD
- Agilent Technologies, Inc
- QIAGEN
- HTG Molecular Diagnostics, Inc.
- Danaher Hologic, Inc.
- BIOMÉRIEUX
GLOBALONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY PRODUCT TYPE
- Services
- Assay Kits & Reagents
GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY CANCER TYPE
- Lung Cancer
- Hematological Cancer
- Breast Cancer
- Colorectal Cancer
- Other
GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY TECHNOLOGY
- qPCR
- dPCR
- Next-Generation Sequencing
- Others
GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY END-USE
- Reference Laboratories
- Hospitals
- Others
GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Onco-hematology Molecular Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Onco-hematology Molecular Testing Market Snippet by Product Type
2.1.2. Onco-hematology Molecular Testing Market Snippet by Cancer Type
2.1.3. Onco-hematology Molecular Testing Market Snippet by Technology
2.1.4. Onco-hematology Molecular Testing Market Snippet by End-use
2.1.5. Onco-hematology Molecular Testing Market Snippet by Country
2.1.6. Onco-hematology Molecular Testing Market Snippet by Region
2.2. Competitive Insights
3. Onco-hematology Molecular Testing Key Market Trends
3.1. Onco-hematology Molecular Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Onco-hematology Molecular Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Onco-hematology Molecular Testing Market Opportunities
3.4. Onco-hematology Molecular Testing Market Future Trends
4. Onco-hematology Molecular Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Onco-hematology Molecular Testing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Onco-hematology Molecular Testing Market Landscape
6.1. Onco-hematology Molecular Testing Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Onco-hematology Molecular Testing Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
7.1.2. Services
7.1.3. Assay Kits & Reagents
8. Onco-hematology Molecular Testing Market – By Cancer Type
8.1. Overview
8.1.1. Segment Share Analysis, By Cancer Type, 2022&2030 (%)
8.1.2. Lung Cancer
8.1.3. Hematological Cancer
8.1.4. Breast Cancer
8.1.5. Colorectal Cancer
8.1.6. Other
9. Onco-hematology Molecular Testing Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2022&2030 (%)
9.1.2. qPCR
9.1.3. dPCR
9.1.4. Next-Generation Sequencing
9.1.5. Others
10. Onco-hematology Molecular Testing Market – By End-use
10.1. Overview
10.1.1. Segment Share Analysis, By End-use, 2022&2030 (%)
10.1.2. Reference Laboratories
10.1.3. Hospitals
10.1.4. Others
11. Onco-hematology Molecular Testing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Onco-hematology Molecular Testing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Onco-hematology Molecular Testing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Onco-hematology Molecular Testing Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Onco-hematology Molecular Testing Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Onco-hematology Molecular Testing Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Onco-hematology Molecular Testing Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. F. Hoffmann-La Roche Ltd
12.2.2. DiaSorin Molecular LLC
12.2.3. Abbott
12.2.4. Thermo Fisher Scientific Inc.
12.2.5. Bayer AG
12.2.6. GenMark Diagnostics, Inc
12.2.7. Biocartis
12.2.8. BD
12.2.9. Agilent Technologies, Inc
12.2.10. QIAGEN
12.2.11. HTG Molecular Diagnostics, Inc.
12.2.12. Danaher Hologic, Inc.
12.2.13. BIOMÉRIEUX
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
